The National Medical Products Administration (NMPA) in China has recently approved Sichuan Kelun Biotech Biopharmaceutical’s Sutaray (trastuzumab botidotin) for the treatment of adult patients with... The post Sutaray NMPA approval marks major milestone in China HER2-positive breast cancer market, says GlobalData appeared first on GlobalData.| GlobalData
Lashelle Scott of Houston remembers the exact moment she was diagnosed with breast cancer. “I thought, what do I do now? How do I survive this – and how do I pay for it?” she recalls. As a self-employed contractor and former political consultant, Lashelle didn’t have health insurance at the time. As she tried […] The post Lashelle’s Story: Bridging the Disparities Gap in Houston appeared first on Susan G. Komen®.| Susan G. Komen®